NYSE: SMGScotts Miracle Gro Co Stock
$61.15-2.59 (-4.06%)
Updated Jun 13, 2025
SMG Price
$61.15
Fair Value Price
N/A
Market Cap
$3.53B
52 Week Low
$45.61
52 Week High
$93.90
P/E
101.92x
P/B
-12.17x
P/S
0.91x
PEG
0.7x
Dividend Yield
4.32%
Revenue
$3.45B
Earnings
$36.10M
Gross Margin
28%
Operating Margin
6.31%
Profit Margin
1%
Debt to Equity
-13.19
Operating Cash Flow
$449M
Beta
1.25
Next Earnings
Jul 30, 2025
Ex-Dividend
N/A
Next Dividend
N/A
SMG Overview
The Scotts Miracle-Gro Company manufactures and sells products for lawn and garden care, and indoor and hydroponic gardening. Its products are sold through home centers, warehouse clubs, large hardware chains, hardware stores, nurseries, garden centers, e-commerce platforms, food and drug stores, as well as indoor gardening and hydroponic distributors, retailers, and growers. The Scotts Miracle-Gro Company was founded in 1868 and is headquartered in Marysville, OH.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine SMG's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
B
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Agricultural Input
Industry Rating
B
SMG
Ranked#8 of 12
Ranked#8 of 12
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $83.87 | A | |
| $99.93 | B | |
| $35.76 | C |
Be the first to know about important SMG news, forecast changes, insider trades & much more!
SMG News
Overview
Due Diligence Score
–
Industry Average (30)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how SMG scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
SMG ($61.15) is trading above its intrinsic value of $34.01, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
SMG is poor value based on its earnings relative to its share price (101.92x), compared to the US market average (31.36x)
P/E vs Market Valuation
SMG is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more SMG due diligence checks available for Premium users.
Valuation
SMG price to earnings (PE)
For valuing profitable companies with steady earnings
Company
101.92x
Industry
41.1x
Market
31.36x
SMG is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
SMG is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
SMG price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-12.17x
Industry
1.66x
SMG price to earnings growth (PEG)
For valuing profitable companies with growth potential
SMG is good value based... subscribe to Premium to read more.
PEG Value Valuation
SMG's financial health
Profit margin
Revenue
$1.4B
Net Income
$217.5M
Profit Margin
15.3%
SMG's Earnings (EBIT) of $218.10M... subscribe to Premium to read more.
Interest Coverage Financials
SMG's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$3.5B
Liabilities
$3.8B
Debt to equity
-13.19
SMG's short-term assets ($1.73B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
SMG's long-term liabilities ($2.81B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
SMG's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
SMG's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$188.1M
Investing
-$11.4M
Financing
-$169.8M
SMG's operating cash flow ($449.30M)... subscribe to Premium to read more.
Debt Coverage Financials
SMG vs Agricultural Input Stocks
Scotts Miracle Gro Co Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.